CERo Therapeutics Holdings Inc (NASDAQ:CERO) price closed higher on Tuesday, November 12, and jumping 36.53% above its previous close.
A look at the daily price movement shows that the last close reads $0.20, with intraday deals fluctuated between $0.2275 and $0.3299. The company’s 5Y monthly beta was ticking -0.463. Taking into account the 52-week price action we note that the stock hit a 52-week high of $12.80 and 52-week low of $0.06. The stock added 171.12% on its value in the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CERo Therapeutics Holdings Inc, which has a market valuation of $40.22 million, is expected to release its quarterly earnings report in December.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give CERO a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that CERO’s price is at present 179.27% off the SMA20 and 177.94% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 87.09, with weekly volatility standing at 29.65%. The indicator jumps to 14.19% when calculated based on the past 30 days. CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s beta value is holding at 0.22, while the average true range (ATR) indicator is currently reading 0.03.
An analysis of the CERo Therapeutics Holdings Inc (NASDAQ:CERO) stock in terms of its daily trading volume indicates that the 3-month average is 30.96 million. However, this figure increases on the past 10-day timeline to an average of 147.37 million.
Current records show that the company has 51.35M in outstanding shares. The insiders’ percentage holdings are 20.25% of outstanding shares while the percentage share held by institutions stands at 1.01%. The stats also highlight that short interest as of 2024-10-15, stood at 0.44 million shares, which puts the short ratio at the time at 0.02. From this we can glean that short interest is 57.00 of company’s current outstanding shares. Notably, we see that shares short in October rose slightly given the previous month’s figure stood at 0.27 million. But the -97.57% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
